Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Myopia
Share your love
AEVR’s executive director on #SeeWhatMatters and safeguarding the National Eye Institute
#SeeWhatMatters is a national advocacy campaign to raise awareness about the importance of federally funded vision research and to protect the independence of the National Eye Institute amid proposed structural changes to the NIH. (Image courtesy of #SeeWhatMatters) The Alliance…
Lifestyle and sleep-related behaviours in children with myopia – BMC Ophthalmology
Lifestyle and sleep-related behaviours in children with myopia BMC Ophthalmology Source: Author: | Date: 2025-02-26 08:00:00 Source: Author: | Date: 2025-02-26 08:00:00
OneSight and WHO Partner on SPECS 2030
The OneSight EssilorLuxottica Foundation has entered a strategic partnership with the World Health Organization (WHO) as a global collaborator in the SPECS 2030 initiative. This alliance aims to expedite progress toward achieving the first global target for effective refractive error…
Global Myopia Surge in Children Predicted to Hit 740M by 2050
A new analysis published in the British Journal of Ophthalmology reveals that nearly one in three children and teens worldwide is expected to be affected by myopia by 2050, translating to over 740 million cases. This trend reflects a significant…
Ray Tracing Optimization – Myopic LASIK & AI
Laser-assisted in situ keratomileusis (LASIK) has become one of the most effective and safe methods for correcting refractive error with laser corneal intervention, as evidenced by the long and large number of publications in the peer-reviewed literature. In recent years,…
Eyenovia Pediatric Myopia Trial Falls Short
Eyenovia has announced that its Phase 3 CHAPERONE study, aimed at treating pediatric progressive myopia, failed to meet its primary endpoint. The trial evaluated the company’s proprietary drug-device combination using low-dose atropine delivered via the Optejet platform. A review by…
Foundation Fighting Blindness Launches Gyrate Atrophy Study
The Foundation Fighting Blindness has launched a natural history study targeting gyrate atrophy, a rare and sight-threatening inherited retinal disease. Spearheading this initiative are esteemed researchers Dr. Mandeep S. Singh, MD, PhD, and Dr. David Valle, MD, from the Wilmer…
What Is Suprachoroidal Hemorrhage? | OBN
What Is Suprachoroidal Hemorrhage? Suprachoroidal hemorrhage is a sight-destroying pathology. It arises when there is a rupture of long or short ciliary arteries during an intraocular surgery and blood is contained in the space between the choroid and the sclera.…
New Consensus: Myopia Should Be Classified as a Disease
A new consensus report from the National Academies of Sciences, Engineering, and Medicine urges that myopia be classified as a disease requiring medical diagnosis. The report emphasizes the growing prevalence of myopia globally, which is projected to affect 5 billion…
COVID-19 and Eye Care: It’s Impact and Implications
COVID-19, a global pandemic caused by the SARS-CoV-2 virus, has affected nearly every aspect of healthcare, including eye care services. Since the virus was first identified in December 2019, it has caused significant disruptions in healthcare systems worldwide. This article…